There is currently no universally accepted BPC-157 dosage because it has not been approved specifically for weight loss and research is still ongoing
Serious reactions are very rare, which is exactly why a trained healthcare professional must always be the one to give you the shot
Trials such as CREDENCE and DAPA-CKD show that these agents reduce albuminuria, slow eGFR decline, and lower risks of end-stage kidney disease
Also, they may improve ovulation in #PCOS
For reference, Mounjaro and Zepbound pens use a proprietary concentration and delivery mechanism
Topline Novo Nordisk said Thursday it will sue Hims & Hers after the online pharmaceutical retailer announced a much cheaper, compounded version of the Wegovy weight-loss pilljust over 7 months after Novo Nordisk terminated their distribution agreement, citing concerns over mass-compounding activities, a move that sent the companys stock falling